Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical clotrimazole versus terbinafine for otomycosis
ISRCTN17978168Phase 3Completed
- Sponsor
- Universidad Autónoma de Sinaloa
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in otomycosis comparing Clotrimazole arm with Terbinafine arm (2 arms). Primary endpoint: Resolution of otomycosis. Started Aug 2022; status: completed.
02
Drugs
clotrimazoleTerbinafine
03
Conditions
otomycosis
Beyond the preview
Go deeper on ISRCTN17978168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN17978168.